These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15912763)

  • 1. [Immunotherapy for brain tumor: don't get "Lost in Translation"].
    Okada H
    No Shinkei Geka; 2005 May; 33(5):433-42. PubMed ID: 15912763
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological therapy of human tumors by gene-modified cellular vaccines.
    Parmiani G
    Folia Biol (Praha); 2000; 46(6):207-9. PubMed ID: 11140852
    [No Abstract]   [Full Text] [Related]  

  • 3. [CTL precursor-oriented peptide vaccine therapy for malignant glioma].
    Yajima N; Yamanaka R; Tanaka R; Shigemori M; Mine T; Itoh K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():582-7. PubMed ID: 16201585
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R; Itoh K
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurosurgery and molecular biology: (series 10) gene therapy and biological therapy for brain tumors].
    Okada H
    No Shinkei Geka; 1999 Jan; 27(1):9-17. PubMed ID: 10024979
    [No Abstract]   [Full Text] [Related]  

  • 6. The contenders. Vaccines and viruses take aim at cancer cells.
    Clancy F
    Minn Med; 2005 Apr; 88(4):24-8. PubMed ID: 15940888
    [No Abstract]   [Full Text] [Related]  

  • 7. Peptide vaccine therapy for childhood gliomas.
    Pollack IF; Jakacki RI; Butterfield LH; Okada H
    Neurosurgery; 2013 Aug; 60 Suppl 1():113-9. PubMed ID: 23839362
    [No Abstract]   [Full Text] [Related]  

  • 8. Glioma-specific antigens for immune tumor therapy.
    Skog J
    Expert Rev Vaccines; 2006 Dec; 5(6):793-802. PubMed ID: 17184218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell fusion technology vaccine tested in kidney cancer clinical trial.
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):620. PubMed ID: 12503204
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy of malignant gliomas.
    Jaeckle KA
    Semin Oncol; 1994 Apr; 21(2):249-59. PubMed ID: 8153668
    [No Abstract]   [Full Text] [Related]  

  • 11. Issues on clinical applications of cancer vaccines.
    Disis ML; Schiffman K
    J Immunother; 2001; 24(2):104-5. PubMed ID: 11265766
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor vaccination for high-grade glioma.
    Schlegel PG; Eyrich M; Kramm C; van Gool S
    Pediatr Blood Cancer; 2010 Dec; 55(7):1437. PubMed ID: 20848641
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccine for aggressive brain tumors may prolong survival.
    Health News; 2004 Dec; 10(12):7. PubMed ID: 15645564
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
    J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agenus cancer vaccine extends survival of GBM patients.
    Riedmann EM
    Hum Vaccin Immunother; 2014; 10(2):252-3. PubMed ID: 24963517
    [No Abstract]   [Full Text] [Related]  

  • 17. Technology evaluation: Onyvax-P, Onyvax.
    Doehn C; Böhmer T; Jocham D
    Curr Opin Mol Ther; 2005 Oct; 7(5):511-9. PubMed ID: 16248287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
    Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC
    Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
    Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
    Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
    Klingebiel T; Bader P; Hollatz G; Koehl U; Lehrnbecher T; Meisel R; Dilloo D
    Klin Padiatr; 2006; 218(6):355-65. PubMed ID: 17080339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.